Adam Havey, EVP, Business Operations at Emergent BioSolutions Inc. (EBS), sold 314 shares at $63.50 ($20K) on 2018-10-17, disclosed to the SEC on 2018-10-24.
Scheduled sale ($20k) by EVP, Business Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |